Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Stephanie Lugardon"'
Autor:
Karine Desboeuf, Stephanie Lugardon, Pierre Fernet, Maryse Lapeyre-Mestre, Jean-Louis Montastruc
Publikováno v:
Bulletin de l'Académie Nationale de Médecine. 192:421-431
RESUME Les differentes methodes (notification spontanee ou utilisation de bases de donnees medicales) utilisees pour identifier et quantifier les effets indesirables medicamenteux souffrent de l’absence d’exhaustivite. La declaration des effets i
Autor:
H. Roussel, Maryse Lapeyre-Mestre, Vincent Sciortino, Stephanie Lugardon, Jean-Louis Montastruc
Publikováno v:
European Journal of Clinical Pharmacology. 63:801-807
The use of triptans (5-HT agonists) in the treatment of migraine is associated with a potential increasing risk of cardiovascular events and raises the question of the relationship between overuse and the occurrence of ischemic events. The aim of thi
Autor:
Robert Bourrel, Maryse Lapeyre-Mestre, Stephanie Lugardon, Vincent Sciortino, Jean-Louis Montastruc, Henri Roussel
Publikováno v:
Therapies. 61:109-114
Resume L’objectif de cette etude etait de decrire le profil des utilisateurs d’anti-inflammatoires non steroidiens (AINS). A partir des donnees de l’Assurance Maladie, nous avons isole les patients affilies au regime general de Midi-Pyrenees ay
Publikováno v:
European Journal of Clinical Pharmacology. 60:673-677
To evaluate the gastrointestinal safety of cyclo-oxygenase-2 inhibitors under their real conditions of use. Case/non-case study. Adverse drug reactions (ADRs) in adults recorded in the French Pharmacovigilance Database between 25 May 2000 and 31 Dece
Autor:
Mireille Gony, Stephanie Lugardon, Jean-Louis Montastruc, Maryse Lapeyre-Mestre, Haleh Bagheri
Publikováno v:
Therapies. 59:201-205
Therapeutic advance is defined by an improvement in effectiveness, safety and/or convenience. In this article, these three criteria were applied to currently marketed coxibs (celecoxib, rofecoxib), using data from clinical trials and pharmacoepidemio
Autor:
Karine Desboeuf, Maryse Lapeyre-Mestre, Jean-Louis Montastruc, Stephanie Lugardon, Pierre Fernet
Publikováno v:
British journal of clinical pharmacology. 62(2)
Aims There is evidence that different methods used to identify and quantify adverse drug reactions (ADR) in hospitals are not exhaustive (spontaneous reporting or computerized medical databases). The combination of these different sources of data cou
Autor:
Jean-Louis, Montastruc, Maryse, Lapeyre-Mestre, Mireille, Gony, Stephanie, Lugardon, Haleh, Bagheri
Publikováno v:
Therapie. 59(2)
Therapeutic advance is defined by an improvement in effectiveness, safety and/or convenience. In this article, these three criteria were applied to currently marketed coxibs (celecoxib, rofecoxib), using data from clinical trials and pharmacoepidemio